These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 21812498)

  • 1. Is antiarrhythmic treatment in the elderly different? a review of the specific changes.
    Deneer VH; van Hemel NM
    Drugs Aging; 2011 Aug; 28(8):617-33. PubMed ID: 21812498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Valembois L; Audureau E; Takeda A; Jarzebowski W; Belmin J; Lafuente-Lafuente C
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005049. PubMed ID: 31483500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Lafuente-Lafuente C; Valembois L; Bergmann JF; Belmin J
    Cochrane Database Syst Rev; 2015 Mar; (3):CD005049. PubMed ID: 25820938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A benefit-risk assessment of class III antiarrhythmic agents.
    Brendorp B; Pedersen O; Torp-Pedersen C; Sahebzadah N; Køber L
    Drug Saf; 2002; 25(12):847-65. PubMed ID: 12241126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antiarrhythmic drugs.
    Nestico PF; Morganroth J; Horowitz LN
    Drugs; 1988 Mar; 35(3):286-319. PubMed ID: 3286214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentially significant drug interactions of class III antiarrhythmic drugs.
    Yamreudeewong W; DeBisschop M; Martin LG; Lower DL
    Drug Saf; 2003; 26(6):421-38. PubMed ID: 12688833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral antiarrhythmic drugs in converting recent onset atrial fibrillation.
    Deneer VH; Borgh MB; Kingma JH; Lie-A-Huen L; Brouwers JR
    Pharm World Sci; 2004 Apr; 26(2):66-78. PubMed ID: 15085940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Lafuente-Lafuente C; Longas-Tejero MA; Bergmann JF; Belmin J
    Cochrane Database Syst Rev; 2012 May; (5):CD005049. PubMed ID: 22592700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sotalol: An important new antiarrhythmic.
    Anderson JL; Prystowsky EN
    Am Heart J; 1999 Mar; 137(3):388-409. PubMed ID: 10047618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dofetilide, a new class III antiarrhythmic agent.
    Lenz TL; Hilleman DE
    Pharmacotherapy; 2000 Jul; 20(7):776-86. PubMed ID: 10907968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
    Nestico PF; Morganroth J
    Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dofetilide: a new class III antiarrhythmic agent.
    Roukoz H; Saliba W
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):9-19. PubMed ID: 17187453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dofetilide, a novel class III antiarrhythmic agent.
    Rasmussen HS; Allen MJ; Blackburn KJ; Butrous GS; Dalrymple HW
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S96-105. PubMed ID: 1279316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrhythmias in the intensive care patient.
    Trappe HJ; Brandts B; Weismueller P
    Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.